DENALI
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 15 May 2025)
What this means for you
Registered since 04 Dec 2018. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 04 Dec 2028: the §8 & §9 renewal).
Record
- Serial number
- 86557009
- Registration number
- 5622978
- Mark type
- Word mark
- Filed
- 08 Mar 2015
- Published for opposition
- 28 Jul 2015
- Registered
- 04 Dec 2018
- Next maintenance filing
- §8 & §9 renewal, due by 04 Dec 2028 (grace period to 04 Jun 2029)
- Attorney of record
- Chelseaa Larsen
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for diagnosing and treating neurodegenerative diseases
Owner
- Denali Therapeutics Inc., South San Francisco, CA, US
- Denali Therapeutics Inc., San Francisco, CA, US
- Denali Therapeutics Inc., San Francisco, CA, US
Board proceedings on this mark
The owner also pleads this mark in 1 other Board proceeding.
Prosecution history
- 15 May 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 15 May 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 15 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 04 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 04 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 04 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 22 Jan 2025 — TEAS SECTION 8 & 15 RECEIVED
- 04 Dec 2023 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 20 Aug 2019 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Aug 2019 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 04 Dec 2018 — REGISTERED-PRINCIPAL REGISTER
- 02 Nov 2018 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Nov 2018 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 24 Sept 2018 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Sept 2018 — USE AMENDMENT FILED